NO EVIDENCE OF GENETIC-HETEROGENEITY IN BRAZILIAN FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY FAMILIES (FSHD) WITH 4Q MARKERS

被引:21
作者
PASSOSBUENO, MR
WIJMENGA, C
TAKATA, RE
MARIE, SKN
VAINZOF, M
PAVANELLO, RC
HEWITT, JE
BAKKER, E
CARVALHO, A
AKIYAMA, J
FRANTS, RR
ZATZ, M
机构
[1] DEPT CELL & STRUCT BIOL,MANCHESTER,ENGLAND
[2] LEIDEN UNIV,DEPT HUMAN GENET,2300 RA LEIDEN,NETHERLANDS
[3] UNIV SAO PAULO,FAC MED,SAO PAULO,BRAZIL
基金
巴西圣保罗研究基金会;
关键词
D O I
10.1093/hmg/2.5.557
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The gene responsible for facioscapulohumeral muscular dystrophy (FSHD), an autosomal dominant neuromuscular condition, has been mapped to chromosome 4. Until recently, the two closest available markers were D4S139 and D4S163 but a new marker (p13E-11) which recognizes de novo rearrangements in isolated cases of FSHD characterized by shorter EcoRI fragments has been now identified. Linkage analysis in FSHD families with p13E-11 shows that usually a smaller fragment segregates with the disease gene among the affected individuals from each genealogy. In the present paper, we report the results from linkage analysis with the marker loci D4Sl63 and D4S139 in 6 FSHD families and with p13E-11 in these and in 6 other additional Brazilian families (total of 12). The results from such analysis do not suggest genetic heterogeneity for FSHD in our population. In 11 out of the 12 families studied with p13E-11, a shorter specific EcoRI band was found to segregate in all affected patients from each genealogy. In one family, the normal individuals had a smaller EcoRI fragment than the affected ones. The size of the EcoRI fragments detected with p13E-11 varied from 13.5 to 29 kb but was constant within each genealogy. Our results suggest that the use of the marker p13E-11 for preclinical and prenatal diagnosis should be done only in families in which it is possible to identify the fragments segregating among the affected individuals.
引用
收藏
页码:557 / 562
页数:6
相关论文
共 26 条
[1]   A HIGHLY POLYMORPHIC VNTR LOCUS ON THE LONG ARM OF CHROMOSOME-4 [J].
ALTHERR, MR ;
WASMUTH, JJ ;
NAKAMURA, Y ;
WHITE, R .
NUCLEIC ACIDS RESEARCH, 1991, 19 (05) :1168-1168
[2]  
EGGERS S, 1993, IN PRESS J MED GENET
[3]  
FEINBERG AP, 1983, ANAL BIOCHEM, V132, P509
[4]   CLINICAL-FEATURES AND CLASSIFICATION OF THE MUSCULAR-DYSTROPHIES [J].
GARDNERMEDWIN, D .
BRITISH MEDICAL BULLETIN, 1980, 36 (02) :109-115
[5]  
GILBERT JR, 1992, AM J HUM GENET, V51, P424
[6]  
Iqbal Z., 1992, American Journal of Human Genetics, V51, pA191
[7]   ANALYSIS OF HUMAN Y-CHROMOSOME-SPECIFIC REITERATED DNA IN CHROMOSOME VARIANTS [J].
KUNKEL, LM ;
SMITH, KD ;
BOYER, SH ;
BORGAONKAR, DS ;
WACHTEL, SS ;
MILLER, OJ ;
BREG, WR ;
JONES, HW ;
RARY, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1977, 74 (03) :1245-1249
[8]   STRATEGIES FOR MULTILOCUS LINKAGE ANALYSIS IN HUMANS [J].
LATHROP, GM ;
LALOUEL, JM ;
JULIER, C ;
OTT, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (11) :3443-3446
[9]   ESTIMATION OF AGE-DEPENDENT PENETRANCE IN FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY BY MINIMIZING ASCERTAINMENT BIAS [J].
LUNT, PW ;
COMPSTON, DAS ;
HARPER, PS .
JOURNAL OF MEDICAL GENETICS, 1989, 26 (12) :755-760
[10]   GENETIC-COUNSELING IN FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY [J].
LUNT, PW ;
HARPER, PS .
JOURNAL OF MEDICAL GENETICS, 1991, 28 (10) :655-664